Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


2 Antimicrob Agents Chemother
2 Clin Infect Dis
1 Emerg Infect Dis
1 Int J Tuberc Lung Dis
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Antimicrob Agents Chemother

  1. YU W, Buhari Y, Wang S, Tian X, et al
    Sterilizing Effects of Novel Regimens Containing TB47, Clofazimine and Linezolid in a Murine Model of Tuberculosis.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0070621. doi: 10.1128/AAC.00706.
    PubMed         Abstract available

  2. VAN SCHIE L, Borgers K, Michielsen G, Plets E, et al
    Exploration of synergistic action of cell wall-degrading enzymes against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0065921. doi: 10.1128/AAC.00659.
    PubMed         Abstract available

    Clin Infect Dis

  3. RADTKE KK, Hesseling AC, Winckler JL, Draper HR, et al
    Moxifloxacin pharmacokinetics, cardiac safety, and dosing for the treatment of rifampicin-resistant tuberculosis in children.
    Clin Infect Dis. 2021 Jul 21. pii: 6324883. doi: 10.1093.
    PubMed         Abstract available

  4. TAVAZIVA G, Harris M, Abidi SK, Geric C, et al
    Chest X-ray analysis with deep learning-based software as a triage test for pulmonary tuberculosis: an individual patient data meta-analysis of diagnostic accuracy.
    Clin Infect Dis. 2021 Jul 21. pii: 6324830. doi: 10.1093.
    PubMed         Abstract available

    Emerg Infect Dis

  5. LOUIE JK, Agraz-Lara R, Romo L, Crespin F, et al
    Tuberculosis-Associated Hospitalizations and Deaths after COVID-19 Shelter-In-Place, San Francisco, California, USA.
    Emerg Infect Dis. 2021;27:2227-2229.
    PubMed         Abstract available

    Int J Tuberc Lung Dis

  6. SCHULTINK MP, Kerstjens HAM, Ter Beek L, Zondag H, et al
    Assessment of TB treatment on patient well-being.
    Int J Tuberc Lung Dis. 2021;25:315-317.

    PLoS One

  7. SALCEDO J, Rosales M, Kim JS, Nuno D, et al
    Cost-effectiveness of artificial intelligence monitoring for active tuberculosis treatment: A modeling study.
    PLoS One. 2021;16:e0254950.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.